An oncogenic role for the phosphorylated h-subunit of human translation initiation factor eIF3

Lili Zhang, Zeljka McBride, Xiaoyu Pan, Jeanette Rheinhardt, John W.B. Hershey

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

Dysregulation of protein synthesis has been implicated in oncogenesis through a mechanism whereby "weak" mRNAs encoding proteins involved in cell proliferation are strongly translated when the protein synthesis apparatus is activated. Previous work has determined that many cancer cells contain high levels of eIF3h, a protein subunit of translation initiation factor eIF3, and overexpression of eIF3h malignantly transforms immortal NIH-3T3 cells. This is a general feature of eIF3h, as high levels also affect translation, proliferation, and a number of malignant phenotypes of CHO-K1 and HeLa cells and, most significantly, of a primary prostate cell line. Furthermore, overexpressed eIF3h inhibits Myc-dependent induction of apoptosis of primary prostate cells. eIF3h appears to function through translation, as the initial appearance of overexpressed eIF3h in rapidly induced NIH-3T3 cells correlates tightly with the stimulation of protein synthesis and the generation of malignant phenotypes. This oncogenic potential of eIF3h is enhanced by phosphorylation at Ser183. Finally, reduction of eIF3h levels in breast and prostate cancer cell lines by short interfering RNA methods reduces their rates of proliferation and anchorage-independent growth in soft agar. The results provide compelling evidence that high eIF3h levels directly stimulate protein synthesis, resulting in the establishment and maintenance of the malignant state in cells.

Original languageEnglish (US)
Pages (from-to)24047-24060
Number of pages14
JournalJournal of Biological Chemistry
Volume283
Issue number35
DOIs
StatePublished - Aug 29 2008

Fingerprint

Peptide Initiation Factors
NIH 3T3 Cells
Cells
Proteins
Prostate
Translational Peptide Chain Initiation
Phenotype
Cell Line
Phosphorylation
CHO Cells
Protein Subunits
Cell proliferation
HeLa Cells
Small Interfering RNA
Agar
Prostatic Neoplasms
Carcinogenesis
Maintenance
Cell Proliferation
Apoptosis

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

An oncogenic role for the phosphorylated h-subunit of human translation initiation factor eIF3. / Zhang, Lili; McBride, Zeljka; Pan, Xiaoyu; Rheinhardt, Jeanette; Hershey, John W.B.

In: Journal of Biological Chemistry, Vol. 283, No. 35, 29.08.2008, p. 24047-24060.

Research output: Contribution to journalArticle

Zhang, Lili ; McBride, Zeljka ; Pan, Xiaoyu ; Rheinhardt, Jeanette ; Hershey, John W.B. / An oncogenic role for the phosphorylated h-subunit of human translation initiation factor eIF3. In: Journal of Biological Chemistry. 2008 ; Vol. 283, No. 35. pp. 24047-24060.
@article{bb2550b9b4c042cb9a39dc0f026e5340,
title = "An oncogenic role for the phosphorylated h-subunit of human translation initiation factor eIF3",
abstract = "Dysregulation of protein synthesis has been implicated in oncogenesis through a mechanism whereby {"}weak{"} mRNAs encoding proteins involved in cell proliferation are strongly translated when the protein synthesis apparatus is activated. Previous work has determined that many cancer cells contain high levels of eIF3h, a protein subunit of translation initiation factor eIF3, and overexpression of eIF3h malignantly transforms immortal NIH-3T3 cells. This is a general feature of eIF3h, as high levels also affect translation, proliferation, and a number of malignant phenotypes of CHO-K1 and HeLa cells and, most significantly, of a primary prostate cell line. Furthermore, overexpressed eIF3h inhibits Myc-dependent induction of apoptosis of primary prostate cells. eIF3h appears to function through translation, as the initial appearance of overexpressed eIF3h in rapidly induced NIH-3T3 cells correlates tightly with the stimulation of protein synthesis and the generation of malignant phenotypes. This oncogenic potential of eIF3h is enhanced by phosphorylation at Ser183. Finally, reduction of eIF3h levels in breast and prostate cancer cell lines by short interfering RNA methods reduces their rates of proliferation and anchorage-independent growth in soft agar. The results provide compelling evidence that high eIF3h levels directly stimulate protein synthesis, resulting in the establishment and maintenance of the malignant state in cells.",
author = "Lili Zhang and Zeljka McBride and Xiaoyu Pan and Jeanette Rheinhardt and Hershey, {John W.B.}",
year = "2008",
month = "8",
day = "29",
doi = "10.1074/jbc.M800956200",
language = "English (US)",
volume = "283",
pages = "24047--24060",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "35",

}

TY - JOUR

T1 - An oncogenic role for the phosphorylated h-subunit of human translation initiation factor eIF3

AU - Zhang, Lili

AU - McBride, Zeljka

AU - Pan, Xiaoyu

AU - Rheinhardt, Jeanette

AU - Hershey, John W.B.

PY - 2008/8/29

Y1 - 2008/8/29

N2 - Dysregulation of protein synthesis has been implicated in oncogenesis through a mechanism whereby "weak" mRNAs encoding proteins involved in cell proliferation are strongly translated when the protein synthesis apparatus is activated. Previous work has determined that many cancer cells contain high levels of eIF3h, a protein subunit of translation initiation factor eIF3, and overexpression of eIF3h malignantly transforms immortal NIH-3T3 cells. This is a general feature of eIF3h, as high levels also affect translation, proliferation, and a number of malignant phenotypes of CHO-K1 and HeLa cells and, most significantly, of a primary prostate cell line. Furthermore, overexpressed eIF3h inhibits Myc-dependent induction of apoptosis of primary prostate cells. eIF3h appears to function through translation, as the initial appearance of overexpressed eIF3h in rapidly induced NIH-3T3 cells correlates tightly with the stimulation of protein synthesis and the generation of malignant phenotypes. This oncogenic potential of eIF3h is enhanced by phosphorylation at Ser183. Finally, reduction of eIF3h levels in breast and prostate cancer cell lines by short interfering RNA methods reduces their rates of proliferation and anchorage-independent growth in soft agar. The results provide compelling evidence that high eIF3h levels directly stimulate protein synthesis, resulting in the establishment and maintenance of the malignant state in cells.

AB - Dysregulation of protein synthesis has been implicated in oncogenesis through a mechanism whereby "weak" mRNAs encoding proteins involved in cell proliferation are strongly translated when the protein synthesis apparatus is activated. Previous work has determined that many cancer cells contain high levels of eIF3h, a protein subunit of translation initiation factor eIF3, and overexpression of eIF3h malignantly transforms immortal NIH-3T3 cells. This is a general feature of eIF3h, as high levels also affect translation, proliferation, and a number of malignant phenotypes of CHO-K1 and HeLa cells and, most significantly, of a primary prostate cell line. Furthermore, overexpressed eIF3h inhibits Myc-dependent induction of apoptosis of primary prostate cells. eIF3h appears to function through translation, as the initial appearance of overexpressed eIF3h in rapidly induced NIH-3T3 cells correlates tightly with the stimulation of protein synthesis and the generation of malignant phenotypes. This oncogenic potential of eIF3h is enhanced by phosphorylation at Ser183. Finally, reduction of eIF3h levels in breast and prostate cancer cell lines by short interfering RNA methods reduces their rates of proliferation and anchorage-independent growth in soft agar. The results provide compelling evidence that high eIF3h levels directly stimulate protein synthesis, resulting in the establishment and maintenance of the malignant state in cells.

UR - http://www.scopus.com/inward/record.url?scp=53049108498&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=53049108498&partnerID=8YFLogxK

U2 - 10.1074/jbc.M800956200

DO - 10.1074/jbc.M800956200

M3 - Article

C2 - 18544531

AN - SCOPUS:53049108498

VL - 283

SP - 24047

EP - 24060

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 35

ER -